Annual Short Term Debt
$3.40 M
+$505.00 K+17.42%
December 31, 2023
Summary
- As of February 10, 2025, CERE annual short term debt is $3.40 million, with the most recent change of +$505.00 thousand (+17.42%) on December 31, 2023.
- During the last 3 years, CERE annual short term debt has risen by +$1.37 million (+67.19%).
Performance
CERE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$3.52 M
+$111.00 K+3.26%
March 31, 2024
Summary
- As of February 10, 2025, CERE quarterly short term debt is $3.52 million, with the most recent change of +$111.00 thousand (+3.26%) on March 31, 2024.
- Over the past year, CERE quarterly short term debt has increased by +$239.00 thousand (+7.30%).
Performance
CERE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
CERE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.4% | +7.3% |
| 3 y3 years | +67.2% | +37.1% |
| 5 y5 years | +31.3% | +37.1% |
CERE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -28.4% | at high | -30.7% |
| 5 y | 5-year | at high | -40.2% | at high | -42.1% |
| alltime | all time | at high | -40.2% | at high | -42.1% |
Cerevel Therapeutics Holdings Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $3.52 M(+3.3%) |
| Dec 2023 | $3.40 M(+17.4%) | $3.40 M(+3.9%) |
| Sep 2023 | - | $3.28 M(+4.0%) |
| Jun 2023 | - | $3.15 M(+4.0%) |
| Mar 2023 | - | $3.03 M(+4.4%) |
| Dec 2022 | $2.90 M | $2.90 M(+4.1%) |
| Sep 2022 | - | $2.79 M(+4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.67 M(+4.3%) |
| Mar 2022 | - | $2.56 M(+5.2%) |
| Dec 2021 | $2.44 M(+19.7%) | $2.44 M(+4.4%) |
| Sep 2021 | - | $2.33 M(+4.4%) |
| Jun 2021 | - | $2.24 M(+4.5%) |
| Mar 2021 | - | $2.14 M(+5.1%) |
| Dec 2020 | $2.04 M(-21.5%) | $2.04 M |
| Dec 2019 | $2.59 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual short term debt?
- What is the all time high annual short term debt for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual short term debt year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly short term debt?
- What is the all time high quarterly short term debt for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly short term debt year-on-year change?
What is Cerevel Therapeutics Holdings annual short term debt?
The current annual short term debt of CERE is $3.40 M
What is the all time high annual short term debt for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual short term debt is $3.40 M
What is Cerevel Therapeutics Holdings annual short term debt year-on-year change?
Over the past year, CERE annual short term debt has changed by +$505.00 K (+17.42%)
What is Cerevel Therapeutics Holdings quarterly short term debt?
The current quarterly short term debt of CERE is $3.52 M
What is the all time high quarterly short term debt for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly short term debt is $3.52 M
What is Cerevel Therapeutics Holdings quarterly short term debt year-on-year change?
Over the past year, CERE quarterly short term debt has changed by +$239.00 K (+7.30%)